Product Code: ETC7737993 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Fibromyalgia Syndrome Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Fibromyalgia Syndrome Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Fibromyalgia Syndrome Market - Industry Life Cycle |
3.4 Japan Fibromyalgia Syndrome Market - Porter's Five Forces |
3.5 Japan Fibromyalgia Syndrome Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Japan Fibromyalgia Syndrome Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan Fibromyalgia Syndrome Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increase in awareness about fibromyalgia syndrome in Japan |
4.2.2 Rising prevalence of fibromyalgia syndrome in the country |
4.2.3 Technological advancements in diagnosis and treatment of the condition |
4.3 Market Restraints |
4.3.1 Limited availability of approved treatments for fibromyalgia syndrome in Japan |
4.3.2 High cost associated with medications and therapies for the condition |
4.3.3 Lack of healthcare professionals specialized in treating fibromyalgia syndrome |
5 Japan Fibromyalgia Syndrome Market Trends |
6 Japan Fibromyalgia Syndrome Market, By Types |
6.1 Japan Fibromyalgia Syndrome Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Japan Fibromyalgia Syndrome Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Japan Fibromyalgia Syndrome Market Revenues & Volume, By Antidepressants, 2021- 2031F |
6.1.4 Japan Fibromyalgia Syndrome Market Revenues & Volume, By Anticonvulsants, 2021- 2031F |
6.1.5 Japan Fibromyalgia Syndrome Market Revenues & Volume, By Muscle Relaxants, 2021- 2031F |
6.1.6 Japan Fibromyalgia Syndrome Market Revenues & Volume, By Analgesics, 2021- 2031F |
6.2 Japan Fibromyalgia Syndrome Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Japan Fibromyalgia Syndrome Market Revenues & Volume, By Hospitals Pharmacies, 2021- 2031F |
6.2.3 Japan Fibromyalgia Syndrome Market Revenues & Volume, By Drug Stores, 2021- 2031F |
6.2.4 Japan Fibromyalgia Syndrome Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.2.5 Japan Fibromyalgia Syndrome Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Japan Fibromyalgia Syndrome Market Import-Export Trade Statistics |
7.1 Japan Fibromyalgia Syndrome Market Export to Major Countries |
7.2 Japan Fibromyalgia Syndrome Market Imports from Major Countries |
8 Japan Fibromyalgia Syndrome Market Key Performance Indicators |
8.1 Average waiting time for fibromyalgia diagnosis and treatment |
8.2 Number of ongoing clinical trials for new fibromyalgia treatments in Japan |
8.3 Patient satisfaction scores with fibromyalgia management programs |
9 Japan Fibromyalgia Syndrome Market - Opportunity Assessment |
9.1 Japan Fibromyalgia Syndrome Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Japan Fibromyalgia Syndrome Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan Fibromyalgia Syndrome Market - Competitive Landscape |
10.1 Japan Fibromyalgia Syndrome Market Revenue Share, By Companies, 2024 |
10.2 Japan Fibromyalgia Syndrome Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |